Summit Therapeutics (NASDAQ: SMMT) experienced a significant 30% decrease in its stock on Friday, May 30th, closing at $18. This sudden decline came even though the stock had doubled within the past year, driven by favorable updates regarding its lung cancer medication, ivonescimab.

ZBIO Investors Have Opportunity to Lead Zenas BioPharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
ZBIO PRNewsWire — June 02, 2025LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Zenas BioPharma, Inc. ("Zenas" or "the Company") (NASDAQ: ZBIO) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering ("IPO") conducted on September 13, 2024, are encouraged to contact the firm before June 16, 2025.

CODI INVESTOR ALERT: Compass Diversified Holdings Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit — Neutral
CODI PRNewsWire — June 02, 2025SAN DIEGO , June 2, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Compass Diversified Holdings (NYSE: CODI) publicly traded securities between May 1, 2024 and May 7, 2025, inclusive (the "Class Period"), have until Tuesday, July 8, 2025 to seek appointment as lead plaintiff of the Compass Diversified class action lawsuit. Captioned Augenbaum v.

Brookfield Residential and Trez Capital Form Joint Venture to Complete a Master-Planned Community within the Florida Market — Neutral
BN PRNewsWire — June 02, 2025COSTA MESA, Calif. and VANCOUVER, BC , June 2, 2025 /PRNewswire/ -- Brookfield Residential, a leading land developer and homebuilder in North America, is pleased to announce the launch of a strategic joint venture with Trez Capital, a leader in North American commercial real estate investments, to develop a new master-planned community in Central Florida named Osprey Creek.

DEADLINE TOMORROW: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025 — Neutral
VTRS PRNewsWire — June 02, 2025PHILADELPHIA , June 2, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) on behalf of purchasers of Viatris securities between August 8, 2024 through February 26, 2025, inclusive (the "Class Period"). Investor Deadline: Investors who purchased or acquired Viatris securities during the Class Period may, no later than JUNE 3, 2025 , seek to be appointed as a lead plaintiff representative of the class.

Diana Shipping Inc. Announces Time Charter Contract for m/v Newport News With Bohai Ocean Shipping — Neutral
DSX GlobeNewsWire — June 02, 2025ATHENS, Greece, June 02, 2025 (GLOBE NEWSWIRE) -- Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate wholly-owned subsidiary, it has entered into a time charter contract with Bohai Ocean Shipping (Singapore) Holding Pte. Ltd., for one of its Newcastlemax dry bulk vessels, the m/v Newport News. The gross charter rate is US$25,000 per day, minus a 5.00% commission paid to third parties, for a period until minimum September 1, 2026 up to maximum October 31, 2026. The charter is expected …

Here's Why Hold Strategy Is Apt for Pembina Pipeline Stock Now — Negative
PBA Zacks Investment Research — June 02, 2025PBA offers robust earnings, dividend growth and strategic contracts but faces commodity volatility, regulatory risks and project delays.

American Resources & ReElement Extend Antimony Refining Deal — Positive
AREC Zacks Investment Research — June 02, 2025AREC expands refining deal with ReElement, targeting more than $29 million in annual revenues from U.S. defense and commercial markets.

SAIC (SAIC) came out with quarterly earnings of $1.92 per share, missing the Zacks Consensus Estimate of $2.14 per share. This compares to earnings of $1.92 per share a year ago.

Mondelēz International Joins the 100+ Accelerator to Help Advance More Sustainable Innovation at Scale — Neutral
MDLZ GlobeNewsWire — June 02, 2025Company becomes sixth corporate partner alongside AB InBev, The Coca-Cola Company, Colgate-Palmolive, Danone, and Unilever Company becomes sixth corporate partner alongside AB InBev, The Coca-Cola Company, Colgate-Palmolive, Danone, and Unilever

TNL Mediagene to Participate in Maxim Group's 2025 Virtual Tech Conference: "Discover the Innovations Reshaping Tomorrow" on June 3-5, Provides Valuation Update — Neutral
TNMG PRNewsWire — June 02, 2025NEW YORK and TOKYO , June 2, 2025 /PRNewswire/ -- TNL Mediagene (Nasdaq: TNMG) (the "Company"), a Tokyo-based next-generation digital media and data group in Asia, has been invited to participate in Maxim Group's 2025 Virtual Tech Conference: "Discover the Innovations Reshaping Tomorrow", taking place on June 3-5, 2025. The conference will focus on how the rapid evolution of technology is paving the way for disruption across all industries, including healthcare, drones, consumer IoT, business solutions, gaming & entertainment, and more.

IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
IOVA PRNewsWire — June 02, 2025LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Iovance Biotherapeutics, Inc. ("Iovance" or "the Company") (NASDAQ: IOVA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 9, 2024 and May 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 14, 2025.

CERo Therapeutics Holdings, Inc. Announces Continued Enhancement of Intellectual Property Portfolio with Two Granted U.S. Patents and European Patent Application Allowance Regarding Company's Lead Compound CER-1236 — Neutral
CERO GlobeNewsWire — June 02, 2025Results in 18 Issued Patents and Allowed Patent Applications Internationally with Nine Total Patent Families SOUTH SAN FRANSCISCO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that deploy phagocytic (i.e.

Coursera Appoints Patrick Supanc as Chief Product Officer — Neutral
COUR Business Wire — June 02, 2025MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Coursera Appoints Patrick Supanc as Chief Product Officer.

Stock Market Live June 2: Trade Troubles Send S&P 500 (VOO) Lower — Negative
VOO 24/7 Wall Street — June 02, 2025President Trump late Friday announced he will double global tariffs on steel imports to 50%.

DNUT Investors Have Opportunity to Lead Krispy Kreme, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
DNUT PRNewsWire — June 02, 2025LOS ANGELES , June 2, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Krispy Kreme, Inc. ("Krispy Kreme" or "the Company") (NASDAQ: DNUT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 25, 2025 and May 7, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 15, 2025.

SailGP is providing real-time odds to gaming platfoms to allow users to place bets SailGP's sports betting push is part of a broader strategic plan to attract new fans, drive deeper engagement and grow the league's popularity

Kidney Health-Focused Vera Therapeutics Stock Price Spikes On Heels Of Successful Trial Data — Positive
VERA Benzinga — June 02, 2025Vera Therapeutics, Inc. VERA saw its share price surge over 65% during the pre-market trading session on Monday after the company released ORIGIN Phase 3 trial data.

The Hanover Insurance Group, Inc. Declares Quarterly Dividend of $0.90 Per Common Share — Neutral
THG PRNewsWire — June 02, 2025WORCESTER, Mass. , June 2, 2025 /PRNewswire/ -- The Hanover Insurance Group, Inc. (NYSE: THG) announced today its board of directors has declared a quarterly dividend of $0.90 per share on the issued and outstanding common stock of the company, payable June 27, 2025, to shareholders of record at the close of business on June 13, 2025.

Canva Accelerates Global Growth and Product Velocity With Snowflake AI Data Cloud — Neutral
SNOW Business Wire — June 02, 2025SAN FRANCISCO--(BUSINESS WIRE)--Snowflake (NYSE: SNOW), the AI Data Cloud company, today announced at its annual user conference, Snowflake Summit 2025, that Canva, the world's leading visual communication platform, is leveraging Snowflake to enhance both the user experience for its global community and drive significant growth in its B2B segment as it expands its relevance and impact across the enterprise. By harnessing the power of Snowflake's platform, Canva is accelerating the delivery of n.
